Aug 16, 2024
1:5
For every 5 shares held, investors received 1. The price per share adjusted from $0.03 to $0.01.
The split itself did not change the total investment value.
Helix BioPharma Corp. (HBPCF) trades on the Other OTC in the Biotechnology industry.
Helix BioPharma Corp. company overviewThe latest split shown was on August 16, 2024. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
This history records one reverse split, on August 16, 2024.
Already premium? Sign in